SEARCH

SEARCH BY CITATION

References

  • Abercrombie E. D., Bonatz A. E. and Zigmond M. J. (1990) Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525, 3644.
  • Adachi Y. U., Yamada S., Satomoto M., Watanabe K., Higuchi H., Kazama T., Doi M. and Sato S. (2006) Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: an in vivo microdialysis study. Brain Res. Bull. 69, 593596.
  • Allen R. P., Barker P. B., Wehrl F., Song H. K. and Earley C. J. (2001) MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56, 263265.
  • Axelrod J. (1972) Dopamine-hydroxylase: regulation of its synthesis and release from nerve terminals. Pharmacol. Rev. 24, 233243.
  • Beard J. L. and Connor J. R. (2003) Iron status and neural functioning. Annu. Rev. Nutr. 23, 4158.
  • Beard J. L., Chen Q., Connor J. and Jones B. C. (1994) Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol. Biochem. Behav. 48, 621624.
  • Beard J. L., Wiesinger J. A. and Connor J. R. (2003) Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev. Neurosci. 25, 308315.
  • Beard J. L., Wiesinger J. A. and Jones B. C. (2006a) Cellular iron concentrations directly affect the expression levels of norepinephrine transporter in PC12 cells and rat brain tissue. Brain Res. 1092, 4758.
  • Beard J. L., Felt B., Schallert T., Burhans M., Connor J. R. and Georgieff M. K. (2006b) Moderate iron deficiency in infancy: biology and behavior in young rats. Behav. Brain Res. 170, 224232.
  • Beard J. L., Unger E. L., Bianco L. E., Paul T., Rundle S. E. and Jones B. C. (2007) Early postnatal iron repletion overcomes lasting effects of gestational iron deficiency in rats. J. Nutr. 137, 11761182.
  • Becker P. M., Jamieson A. O. and Brown W. D. (1993) Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 16, 713716.
  • Blakely R. D. and Bauman A. L. (2000) Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol. 10, 328336.
  • Bolan E. A., Kivell B., Jaligam V. et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol. Pharmacol. 71, 12221232.
  • Bungay P. M., Newton-Vinson P., Isele W., Garris P. A. and Justice J. B. (2003) Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J. Neurochem. 86, 932946.
  • Burbach J. P., Smits S. and Smidt M. P. (2003) Transcription factors in the development of midbrain dopamine neurons. Ann. NY Acad. Sci. 991, 6168.
  • Burhans M. S., Dailey C., Beard Z., Wiesinger J., Murray-Kolb L., Jones B. C. and Beard J. L. (2005) Iron deficiency: differential effects on monoamine transporters. Nutr. Neurosci. 8, 3138.
  • Cass W. A. and Gerhardt G. A. (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176, 259263.
  • Chefer V. I., Zapata A., Shippenberg T. S. and Bungay P. M. (2006) Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J. Neurosci. Methods 155, 187193.
  • Chen Q., Beard J. and Jones B. (1995) Abnormal rat brain monoamine metabolism in iron deficiency anemia. Nutr. Biochem. 6, 486493.
  • Clardy S. L., Wang X., Zhao W., Liu W., Chase G. A., Beard J. L., True Felt B. and Connor J. R. (2006) Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J. Neural Transm. Suppl. 71, 173196.
  • Connor J. R., Boyer P. J., Menzies S. L., Dellinger B., Allen R. P., Ondo W. G. and Earley C. J. (2003) Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61, 304309.
  • Cooper J. R., Bloom F. E. and Roth R. H. (1996) The Biochemical Basis of Neuropharmacology, 7th Edn. Oxford University Press, New York.
  • Dickinson S. D., Sabeti J., Larson G. A., Giardina K., Rubinstein M., Kelly M. A., Grandy D. K., Low M. J., Gerhardt G. A. and Zahniser N. R. (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148156.
  • Earley C. J., Allen R. P., Beard J. L. and Connor J. R. (2000a) Insight into the pathophysiology of restless legs syndrome. J. Neurosci. Res. 62, 623628.
  • Earley C. J., Connor J. R., Beard J. L., Malecki E. A., Epstein D. K. and Allen R. P. (2000b) Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54, 16981700.
  • Earley C. J., Heckler D. and Allen R. P. (2004) The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med. 5, 231235.
  • Erikson K., Pinero D., Connor J. and Beard J. (1997) Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J. Nutr. 127, 20302038.
  • Erikson K. M., Jones B. C. and Beard J. L. (2000) Iron deficiency alters dopamine transporter functioning in rat striatum. J. Nutr. 130, 28312837.
  • Erikson K. M., Jones B. C., Hess E. J., Zhang Q. and Beard J. L. (2001) Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol. Biochem. Behav. 69, 409418.
  • Gainetdinov R. R. and Caron M. G. (2003) Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43, 261284.
  • Goshima Y., Nakamura S. and Misu Y. (1990) L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. Jpn. J. Pharmacol. 53, 4756.
  • Kato T., Kuzuya H. and Nagatsu T. (1974) A simple and sensitive assay for dopamine-beta-hydroxylase activity by dual-wavelength spectrophotometry. Biochem. Med. 10, 320328.
  • Kimmel H. L., Joyce A. R., Carroll F. I. and Kuhar M. J. (2001) Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J. Pharmacol. Exp. Ther. 298, 129140.
  • Kramer-Stickland K., Edmonds A., Bair W. B. III and Bowden G. T. (1999) Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation. Carcinogenesis 20, 21372142.
  • Kwik-Uribe C. L., Gietzen D., German J. B., Golub M. S. and Keen C. L. (2000) Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J. Nutr. 130, 28212830.
  • Mefford I. N. (1981) Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J. Neurosci. Methods 3, 207224.
  • Meiergerd S. M., Patterson T. A. and Schenk J. O. (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764767.
  • Melikian H. E. (2004) Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol. Ther. 104, 1727.
  • Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 76997710.
  • Nelson C., Erikson K., Pinero D. J. and Beard J. L. (1997) In vivo dopamine metabolism is altered in iron-deficient anemic rats. J. Nutr. 127, 22822288.
  • Nishizuka Y. (1992) Membrane phospholipid degradation and protein kinase C for cell signalling. Neurosci. Res. 15, 35.
  • Nordlander N. B. (1954) Restless legs. Br. J. Phys. Med. 17, 160162.
  • O’Keeffe S. T. (2005) Iron deficiency with normal ferritin levels in restless legs syndrome. Sleep Med. 6, 281282.
  • Pinero D., Jones B. and Beard J. (2001) Variations in dietary iron alter behavior in developing rats. J. Nutr. 131, 311318.
  • Prohaska J. R. and Smith T. L. (1982) Effect of dietary or genetic copper deficiency on brain catecholamines, trace metals and enzymes in mice and rats. J. Nutr. 112, 17061717.
  • Refshauge C., Kissinger P. T., Dreiling R., Blank L., Freeman R. and Adams R. N. (1974) New high performance liquid chromatographic analysis of brain catecholamines. Life Sci. 14, 311322.
  • Robinson M. B. (2002) Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80, 111.
  • Ruiz I. G., De La Torre P., Diaz T., Esteban E., Morillas J. D., Munoz-Yague T. and Solis-Herruzo J. A. (2000) Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression. DNA Cell Biol. 19, 167178.
  • Sacchetti P., Brownschidle L. A., Granneman J. and Bannon M. (1999) Characterization of the 5′-flanking region of the human dopamine transporter gene. Mol. Brain Res. 74, 167174.
  • Shimada S., Kitayama S., Lin C. L., Patel A., Nanthakumar E., Gregor P., Kuhar M. and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576578.
  • Smith A. D. and Justice J. B. (1994) The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Methods 54, 7582.
  • Stiasny K., Wetter T. C., Tenkwalder C. and Oertel W. H. (2001) Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism Relat. Disord. 7, 2125.
  • Swanson L. W. (1998) Brain Maps: Structure of the Rat Brain, Revised 2nd Edn. Elsevier Science, Amsterdam.
  • Turjanski N., Lees A. J. and Brooks D. J. (1999) Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 52, 932937.
  • Unger E. L., Paul T., Murray-Kolb L. E., Felt B., Jones B. C. and Beard J. L. (2007) Early iron deficiency alters sensorimotor development and brain monoamines in rats. J. Nutr. 137, 118124.
  • Weinshilboum R. M., Thoa N. B., Johnson D. G., Kopin I. J. and Axelrod J. (1971) Proportional release of norepinephrine and dopamine-hydroxylase from sympathetic nerves. Science 174, 13491351.
  • WHO/UNICEF/UNU (2001) Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. Geneva, World Health Organization.
  • Wiesinger J. A., Buwen J. P., Cifelli C. J., Unger E. L., Jones B. C. and Beard J. L. (2007) Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis. J. Neurochem. 100, 167179.
  • Yehuda S. and Youdim M. B. (1989) Brain iron: a lesson from animal models. Am. J. Clin. Nutr. 50, 618625; discussion 625–619.
  • Youdim M. (1990) Neuropharmacological and neurobiochemical aspects of iron deficency, in Brain, Behavior and Iron in the Infant Diet (DobbingJ., ed.), pp. 83106. Springer-Verlag, London.
  • Youdim M. B., Ben-Shachar D. and Yehuda S. (1989) Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am. J. Clin. Nutr. 50, 607615; discussion 615–607.
  • Zahniser N. R. and Doolen S. (2001) Chronic and acute regulation of Na+/Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 2155.